{"id":15711,"name":"ALSA Ventures","slug":"alsa-ventures","website":"https://www.alsaventures.com","hqGeo":"London, England","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Healthcare","Other"],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":"Biotechnology investor focused on novel therapeutics across the drug development spectrum. Though international, it can be relevant for US companies with global syndication potential.","thesisNarrative":null,"logoUrl":null,"aumUsd":500000000,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"ReproNovo","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Developing a pipeline of innovative treatments to address critical gaps in reproductive medicine and women’s health","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Axovia Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Axovia Therapeutics is developing the first gene therapy to treat diseases caused by cilia dysfunction.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Vantage Biosciences","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Vantage Biosciences is an ALSA Ventures company at the forefront of targeting the root cause of vision loss associated with diabetes.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Promatix","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Promatix is an ALSA Group company using multi-omic insights to develop the next generation of cancer therapeutics.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Montis Biosciences","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Treating chronic inflammatory diseases by modulating the immune status of the perivascular milieu.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Epsilogen","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"World leader in IgE drugs with a pipeline of therapies to treat solid cancer tumours.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Oxford BioTherapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Pipeline of first in class oncology drugs leveraging a proprietary database.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Eccocar","companyUrl":null,"stage":"Other / later-stage not specified","sector":"Technology / unspecified in gathered source","investmentYear":null,"description":"A European tech company; the specific business focus was not visible in the gathered snippet","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":4,"partners":[{"id":51215,"name":"Alek Safarian","title":"Chief Executive Officer","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/aleksafarian","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51216,"name":"Lorna Collings","title":"Chief Financial Officer","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/lorna-collings-b9846537","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51218,"name":"Not specified in source","title":"GP","seniority":null,"focusTags":["therapeutics","biotech"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51217,"name":"Julia Jones","title":"Investment Manager","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/julia-jones-08a85a4","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[{"id":590,"name":"Fund III","vintageYear":2023,"sizeUsd":200000000,"status":"investing","focusAreas":["B2B SaaS","Fintech"]}],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":11323,"name":"Mountain Pine Capital","slug":"mountain-pine-capital","logoUrl":null,"website":"https://mountainpineholdings.com/","stageFocus":["Seed"],"sectorTags":["Consumer","Healthcare","Real Estate"],"hqGeo":"Salt Lake City, UT"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Other","Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":13015,"name":"Nile Ventures","slug":"nile-ventures-13015","logoUrl":null,"website":"https://www.choosenile.com/","stageFocus":["Pre-Seed"],"sectorTags":["Healthcare","SaaS"],"hqGeo":"Lagos, Nigeria"},{"id":13026,"name":"Robin Capital","slug":"robin-capital","logoUrl":null,"website":"https://robincap.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["AI / ML","Fintech","SaaS","Other","Climate / Energy","Healthcare"],"hqGeo":"Berlin, Germany"},{"id":10202,"name":"Celestial Health Innovators","slug":"celestial-health-innovators","logoUrl":null,"website":"https://celestialhealthwellness.co/","stageFocus":["seed+","Series A"],"sectorTags":["Healthcare","Other"],"hqGeo":"New York, NY"},{"id":12096,"name":"TeleHealth Ventures","slug":"telehealth-ventures","logoUrl":null,"website":"https://telehealthventures.com","stageFocus":["Seed"],"sectorTags":["Other","Healthcare"],"hqGeo":"Austin, TX"}],"featuredIn":[{"slug":"pre-seed","displayName":"Pre-Seed Investors","pageType":"stage"},{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"},{"slug":"what-vcs-actually-look-for-pitch-deck","title":"What VCs Actually Look for in a Pitch Deck"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":null}